Actively Recruiting
Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension
Led by General Hospital of Ningxia Medical University · Updated on 2025-07-14
80
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To observe the efficacy and safety of sacral canal block in controlled blood pressure reduction during hip replacement in the elderly, and to provide a better option for controlled blood pressure reduction during clinical hip surgery.
CONDITIONS
Official Title
Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 45 years
- ASA Grade II to III
- Body mass index between 18 and 35 kg/m²
- Willingness to participate and sign informed consent
You will not qualify if you...
- Refusal to participate in the study
- Language or hearing impairments that prevent communication
- Contraindications to sacral canal block
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
General hospital of Ningxia medical university
Yinchuan, Ningxia, China
Actively Recruiting
Research Team
X
Xinli Ni, MD
CONTACT
W
Wenxuan Ma
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here